Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) EBITDA Margin (2023)

Sagimet Biosciences has reported EBITDA Margin over the past 1 years, most recently at 317.65% for Q3 2023.

  • Quarterly results put EBITDA Margin at 317.65% for Q3 2023, changed N/A from a year ago — trailing twelve months through Jun 2024 was 1463.7% (changed N/A YoY), and the annual figure for FY2023 was 1388.1%, changed.
  • EBITDA Margin for Q3 2023 was 317.65% at Sagimet Biosciences.
  • Over the last five years, EBITDA Margin for SGMT hit a ceiling of 317.65% in Q3 2023 and a floor of 317.65% in Q3 2023.